Skip to content

Role and mechanism of differential genes in ovarian cancer

Role and mechanism of differential genes in ovarian cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054372
Enrollment
Unknown
Registered
2021-12-16
Start date
2021-12-02
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Gold Standard:Pathology
Index test:The&#32
expression&#32
of&#32
and&#32
in&#32
cancer&#32
adjacent&#32
were&#32
by&#32

Sponsors

Qingdao Municipal Hospital affiliated to Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have been diagnosed with primary ovarian cancer; 2. The patient signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Preoperative radiotherapy, chemotherapy and targeted therapy; 2. Combined with other serious diseases, such as other malignant tumors, severe liver and kidney insufficiency.

Design outcomes

Primary

MeasureTime frame
m6A regulatory factors and related snoRNA expression;expression of tumor markers;Immunohistochemical detection;

Countries

China

Contacts

Public ContactLuan Shaohong

Qingdao Municipal Hospital affiliated to Qingdao University

13153218209@163.com+86 18561728016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026